6 Drug Stocks Unworthy of Biotech Bull Market

Description:

According to Adam Feuerstein, here are "six biotech and drug stocks with valuations reaching unsustainable levels or which, for various reasons, don't deserve an invitation to the biotech bull market party at all." Read more here.

>>Also: 6 Stocks With Double-Digits Gains and Big Dividends

>>Also: 3 Tech Turnaround Stocks for 2012

Most Viewed Portfolios

View All

Articles

5 Financial Sector Stocks to Trade for Gains in April

04.22.14 | 11:51 AM

BALTIMORE (Stockpickr) -- The back-and-forth is continuing in stocks. After the worst week for the S&P 500 since 2012 at the start of April, stocks...

3 Stocks Rising on Unusual Volume

04.22.14 | 07:43 AM

DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter